MVP
TEVA icon

Miller Value Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,950
Closed -$241K 37
2024
Q4
$241K Hold
10,950
0.1% 31
2024
Q3
$197K Hold
10,950
0.11% 29
2024
Q2
$178K Sell
10,950
-650
-6% -$10.6K 0.11% 28
2024
Q1
$164K Sell
11,600
-1,800
-13% -$25.4K 0.1% 30
2023
Q4
$140K Sell
13,400
-825
-6% -$8.61K 0.08% 42
2023
Q3
$145K Sell
14,225
-67,912
-83% -$693K 0.09% 45
2023
Q2
$618K Sell
82,137
-3,847,647
-98% -$29M 0.41% 37
2023
Q1
$34.8M Sell
3,929,784
-1,217,243
-24% -$10.8M 2.17% 23
2022
Q4
$46.9M Sell
5,147,027
-4,107,848
-44% -$37.5M 3.03% 11
2022
Q3
$74.7M Sell
9,254,875
-79,715
-0.9% -$643K 4.54% 4
2022
Q2
$70.2M Sell
9,334,590
-724,149
-7% -$5.45M 3.57% 8
2022
Q1
$94.5M Buy
10,058,739
+399,220
+4% +$3.75M 3.04% 6
2021
Q4
$77.4M Sell
9,659,519
-88,610
-0.9% -$710K 2.12% 18
2021
Q3
$94.9M Sell
9,748,129
-1,187,654
-11% -$11.6M 2.2% 8
2021
Q2
$108M Buy
10,935,783
+381,718
+4% +$3.78M 2.58% 11
2021
Q1
$122M Buy
10,554,065
+3,414,365
+48% +$39.4M 3.15% 4
2020
Q4
$68.9M Sell
7,139,700
-953,998
-12% -$9.21M 2.1% 18
2020
Q3
$72.9M Buy
8,093,698
+243,226
+3% +$2.19M 2.62% 10
2020
Q2
$96.8M Sell
7,850,472
-67,890
-0.9% -$837K 4.3% 4
2020
Q1
$71.1M Sell
7,918,362
-1,915,705
-19% -$17.2M 4.57% 2
2019
Q4
$96.4M Buy
9,834,067
+1,342,915
+16% +$13.2M 3.42% 7
2019
Q3
$58.4M Buy
8,491,152
+1,990,900
+31% +$13.7M 2.35% 19
2019
Q2
$60M Buy
6,500,252
+1,957,720
+43% +$18.1M 2.28% 20
2019
Q1
$71.2M Buy
4,542,532
+630,730
+16% +$9.89M 2.82% 16
2018
Q4
$60.3M Buy
3,911,802
+6,350
+0.2% +$97.9K 2.74% 13
2018
Q3
$84.1M Buy
3,905,452
+1,316,840
+51% +$28.4M 2.72% 14
2018
Q2
$63M Buy
2,588,612
+393,640
+18% +$9.57M 2.35% 17
2018
Q1
$37.5M Buy
2,194,972
+1,678,860
+325% +$28.7M 1.56% 28
2017
Q4
$9.78M Buy
+516,112
New +$9.78M 0.42% 36